Health & Fit Imperial College Covid-19 Vaccine Trial Expands to More Sites

14:11  24 july  2020
14:11  24 july  2020 Source:   bloomberg.com

Emboldened Anti-Vaccine Movement Threatens The Return To Normality

  Emboldened Anti-Vaccine Movement Threatens The Return To Normality Scientists hoped the battle against the coronavirus would be won in the laboratory. According to the latest updates, a vaccine could be ready to roll out to the public in a matter of months. “We anticipate if everything goes really well that we’ll get an answer as to whether it works by early next year,” professor Robin Shattock, who heads a team developing a coronavirus vaccine at Imperial College London, said this week, per HuffPost U.K. Already, approximately 15 volunteers have been vaccinated as part of the trial, and an additional 200 to 300 participants will be added in the coming weeks, Shattock said.

Imperial College London is advancing the development of an effective COVID - 19 vaccine . We are now recruiting more participants for the first phase of BBC News: revolutionary COVID - 19 vaccine trial begins. The BBC's Fergus Walsh reports as hundreds of volunteers are to take part in the trial of

Imperial Alert. Coronavirus ( COVID - 19 ) updates: We are open for academic year 2020-21. Latest information for student applicants and offer holders, current students and staff.

(Bloomberg) --

Imperial College London’s Covid-19 vaccine trial is expanding to additional sites throughout England, according to a statement dated July 24.

Starting next week, the vaccine, which has received more than 40 million pounds ($51 million) in U.K. government funding in addition to five million pounds philanthropic donations, will be trialled in six additional centers.

Doctors Break Down the Long Road Ahead to Getting a Viable COVID-19 Vaccine

  Doctors Break Down the Long Road Ahead to Getting a Viable COVID-19 Vaccine Be prepared for a long wait.

This article is more than 1 month old. Professor says early vaccines may not stop virus being contracted but prevent recipients developing severe Covid - 19 illness. When injected, the Imperial experimental vaccine instructs muscle cells to produce virus proteins to protect against future infection.

Imperial College London’s vaccine candidate is being developed and trialled thanks to more than £41 million in funding from the UK government and a further £5 For further information on the Imperial vaccine study, including how to take part, please visit the Imperial COVID - 19 Vaccine Trial website .

Preclinical studies have shown that the vaccine produced highly specific antibodies against SARS-CoV-2 in mice, which were able to neutralize the virus, according to the statement.

The vaccine will be trialled in more than 200 people across six locations. The participants at the trial sites will be aged 18-75, and receive two immunizations, four weeks apart.

The Imperial vaccine, which uses self-amplifying RNA, or saRNA, technology, has so far been trialled in 92 volunteers.

For more articles like this, please visit us at bloomberg.com

©2020 Bloomberg L.P.

Video: Coronavirus test could make the difference between life or death: Daxor CEO (Fox Business)

Why it’s still unlikely we’ll have a Covid-19 vaccine before Election Day .
Trump wants a vaccine before November, but his top advisors say that’s near impossible.“The week before last, the head of the Centers for Disease Control Dr. Redfield said it would be summer before the vaccine would become generally available to the public. You said that he was confused and mistaken,” Wallace said.

usr: 1
This is interesting!